Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses
MRD has scaled into a profitable, category-leading MRD diagnostics business, while Immune Medicine has built a differen…
MRD has scaled into a profitable, category-leading MRD diagnostics business, while Immune Medicine has built a differen…
-- Setmelanotide therapy achieved robust, sustained and clinically significant weight loss in patients with acquired HO…
REYKJAVIK, ICELAND (June 15, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechn…
Early mechanistic data positions ETHY-001 as a differentiated candidate in thyroid-eye disease, a space drawing growing…
The shift signals broader biotech convergence, but functional food and nutraceutical formulators should watch how AI-gu…
Antibody-drug conjugate expansion signals broader targeted-delivery innovation that nutraceutical formulators are watch…
Wildfire particulate exposure is emerging as a functional-foods category trigger, with brands eyeing lung-support and a…
Merzenich's neuroplasticity framework is foundational to the fast-growing cognitive supplement and digital therapeutics…
As protein-forward product development accelerates, consumer preference data points to meat quality as a pivotal lever …
The Tyson Foods-owned brand targets the premiumization trend in processed meats, though functional or fortified claims …
The clinical-stage biotech's tablet-based delivery approach draws attention as mucosal immunization research intersects…
Originally developed for vaccine biologics, the C1 platform's high-yield fermentation economics are attracting finished…